Texas Biomed has received a $3.9 million NIH grant to explore how gene-editing technology may help eradicate HIV in the brain.
27-Jul-2022 12:10 PM EDT Add to Favorites
Researchers at Texas Biomed have received approval to work with a weakened, non-harmful version of SARS-CoV-2 in biosafety level 2 (BSL-2) laboratories, which makes it safer, faster and easier to study the virus, its mutations, and to identify new...
21-Jul-2022 10:55 AM EDT Add to Favorites
Texas Biomed tapped for national ‘Dream Team’ developing antivirals against COVID-19 and other threats
Texas Biomedical Research Institute Professor Luis Martinez-Sobrido, PhD, an expert in virology, vaccines and antiviral research, has been recruited to collaborate with three of the nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of...
15-Jul-2022 3:50 PM EDT Add to Favorites
A new software tool makes it easier to study relationships between a host, its microbiome and pathogens like HIV or SARS-CoV-2.
5-May-2022 11:05 AM EDT Add to Favorites
The $5.8 million center at Texas Biomed is one of the inaugural Interdisciplinary NexGen TB Research Advancement Centers (IN-TRAC) funded by the U.S. National Institute of Allergy and Infectious Diseases.
23-Mar-2022 1:35 PM EDT Add to Favorites
Researchers at Texas Biomed and University of Alabama at Birmingham discovered an antibody cocktail against COVID-19 that appears effective against all variants and other coronaviruses. The cocktail has been exclusively licensed to Aridis...
18-Mar-2022 3:20 PM EDT Add to Favorites
Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research Institute report this week in the...
11-Mar-2022 4:00 PM EST Add to Favorites
Medication against the nonhuman primate version of HIV given two weeks after infection helped keep tuberculosis in check.
15-Feb-2022 4:05 PM EST Add to Favorites
See All News
Researcher on TB and the Intersection of Aging and Immune Function Joins Texas Biomed as Vice President for Research
Joanne Turner, Ph.D., a preeminent scientist in tuberculosis (TB) research, has joined the Texas Biomed team, bringing with her a portfolio of research on the immune system in relation to Mycobacterium tuberculosis infection and aging.
19-Oct-2017 1:05 PM EDT